DS9 Document EFTA00658270

From: To: "jeffrey E." <[email protected]> Subject: Re: Date: Fri, 02 Dee 2016 07:30:37 +0000 thank you From: jeffrey E. <[email protected]> To: Sent: Thursday. December 1. 2016 10:25 PM Subject: Re: ill ask, On Thu, Dec 1, 2016 at 11:50 PM Anything non prescription? On Dec 1, 2016, at 8:45 PM, jeffrey E. <[email protected]> wrote: neurontin On Thu, Dec 1, 2016 at 11:41 PM, y wrote: wrote: On Dec 1, 2016, at 8:12 PM, jeffrey E. <[email protected]> wrote: for you? On Thu, Dec 1, 2016 at 11:02 PM, Are you aware of any new, effective migraine treatments? please note The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of JEE Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to jeevacation@gmaitcom and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved wrote: EFTA00658270 please note The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of JEE Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved please note The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of JEE Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA00658271